
MD. Fascinated by Interventional Cardiology | Heart Center University Cologne @UKKoeln | Editorial Board @PCRonline | Visual Media Editor @JACCJournals #JACCCR
Cologne, Germany
Joined January 2018
- Tweets711
- Following595
- Followers988
- Likes1.6K
Pinned Tweet
Future percutaneous approaches might address the large unmet clinical need of severe #vhdTR. Learn more in #JACC. fal.cn/33rMg
Jonathan Curio retweeted
Attending #TCT2026 in San Diego 🇺🇸? So are we!
➡️pcronline.com/News/Congress-…
Follow coverage by @AsherElad , @aayshacader , @ANazmiCalik, @CurioJonathan, @OhnoTuri , @NicolaRyanI1 and @Sticchi_Alex to tay up to date with concise reviews, practical take-home messages and international perspectives on the most anticipated Late-Breaking Clinical Trials and Science.
@sbrugaletta
#interventionalcardiology #science #clinicalresearch
Jonathan Curio retweeted
🔥#ESCCongress 🔥2026 Hot Lines: TRIC-I-HF: Tricuspid intervention in heart failure
📺 pcronline.com/News/Congress-…
@CurioJonathan interviews 🎤 @j_hausleiter about the results of this trial, which he presented at ESC Congress 2026 in Munich, and which was simultaneously published in the @NEJM .
#interventionalcardiology #tricuspid #heartfailure #clinicalresearch
Jonathan Curio retweeted
“Innovators Day is not only for physicians.”
In this interview with @CurioJonathan, @AndreaScotti21 explains how #PCRID brings together physicians, entrepreneurs, innovators and investors to discuss the future of cardiovascular innovation. 🚀🫀
#EuroPCR #PCRID
The 3 innovations competing for #EuroPCR 2️⃣0️⃣2️⃣6️⃣ #PCRID Innovators Day @PCRonline Jon DeHaan Foundation award nicely highlighted by @AndreaScotti21 ⤵️
➡️Join #EuroPCR Ceremony on Thursday, 10:15, Main Arena, to learn the 200k grant winner
@azeemlatib @nickaram @nicolo_piazza
🏆 Jon DeHaan Foundation Award — #PCRID 2026
🔹 TriFlo — TR Tx (Sarkar)
🔹 eVAD System — extravascular LV/RV assist device (Krucoff)
🔹 CARLEN System — first-in-human for functional MR (Kodali)
Three innovations. One prize. Which would you back?
#EuroPCR #treatTR #Innovation
A 1st row seat at the table w/ all key stakeholders - unique experience in Exchange Sessions at #EuroPCR #PCRID @PCRonline Innovators day
➡️Early stage funding, AI in innovation, late-stage reimbursement, Chinese innovation
@AndreaScotti21 @azeemlatib @nickaram @nicolo_piazza
#treatTR beyond T-TEER vs. TTVR:
🎯M. deBonis w/ TriClover at #EuroPCR #PCRID @PCRonline
🎯 Transcath suture based tripple-orifice
🎯Reliable clover shape achieved in animals
➡️Design refinements & in-vivo/animal planned
@AndreaScotti21 @azeemlatib @nickaram @nicolo_piazza
#EuroPCR 2026 is here & yet has its 1st highlight: #PCRID @PCRonline Innovators Day💡
🎯Innovation shaping the future #IC field
🎯Tracks on paths from idea to FIH to clinical practice
➡️If in Paris, join at Palais Congres
@AndreaScotti21 @azeemlatib @nickaram @nicolo_piazza
Jonathan Curio retweeted
Innovation is thriving in #interventionalcardiology, so make sure you follow the news from PCR Innovators Day, happening Monday 18 May in Paris.
@CurioJonathan and @AndreaScotti21 will keep you up to date with all the buzz 🔥and hot news via their #PCRID #SoMe coverage!
@azeemlatib @nickaram @nicolo_piazza
#EuroPCR
Jonathan Curio retweeted
🔥#ACC26 Late-breaking trials 🔥: TRISCEND II
🔗pcronline.com/News/Congress-…
@CurioJonathan .provides his take ✍️on the results of this international, multi-centre, randomised, controlled trial that enrolled 400 patients with symptomatic severe TR.
Presented by Vinod H. Thourani in New Orleans.
#interventionalcardiology #clinicaltrial #cardioX
Jonathan Curio retweeted
🔥#ACC26 Late-breaking trials 🔥: PRO-TAVI
🔗pcronline.com/News/Congress-…
@CurioJonathan provides his take ✍️on this trial that evaluated whether deferral of routine PCI in patients undergoing TAVI is non-inferior in comparison to TAVI with preceding PCI,
The results 📊 were presented by Michiel Voskuil in New Orleans and simultaneously published in @TheLancet.
#interventionalcardiology #clinicaltrial #CardioX #TAVR
Jonathan Curio retweeted
My Toolkit 🧰⚙️🪛:How to perform ELASTA-Clip: lacerating M-TEER devices to enable TMVR
🔗pcronline.com/Cases-resource…
Recurrent mitral regurgitation after M-TEER can create a challenging scenario. Discover the ELASTA-Clip technique and its key steps to enable TMVR!
@CurioJonathan & Matti Adam provide a step-by-step guide to navigate these complex redo cases. Reviewed by @parma.
#interventionalcardiology #cardioX #medtwitter
Jonathan Curio retweeted
Tricuspid regurgitation patients who receive TTVA with the Cardioband see positive cardiac remodeling and functional improvement a year post-procedure, according new a new German real-world study. Read more on #CRTonline. ow.ly/vWuk50XIyPV
Jonathan Curio retweeted
#EIJonAir - Analysis of the NOTION-2 trial xitter.cf/i/broadcasts/1ynJOMYOm…
Jonathan Curio retweeted
Mild PVL after #TAVR is NO LONGER acceptable, especially in low/intermediate risk and younger patients. In #JACCINT @JACCJournals the OCEAN-TAVI registry showed long-term higher mortality and TAV failure even with mild PVL. Minimizing PVL when safe should be routine now.
2 seminar studies including one from our @MountSinaiHeart @MountSinaiNYC @IcahnMountSinai by @ParasuramMD et al shows underexpanded balloon-expandable #TAVR risks early failure and ROUTINE DOUBLE-TAP post dilatation improves balloon-expandable TAV expansion!
Like #PCI where you routinely pre-dilate a lesion and post dilate the stent to avoid ISR, and pre- and post-dilating in redo-PCI for ISR, optimizing valve frame expansion, minimizing PVL during index #TAVR is now paramount to confer durability, REGARDLESS of the type of TAV: balloon-expandable and self-expanding. Best view to do post-dilatation is at RAO CAU with TAV parallax removed to visualize the SHORT AXIS of the native annulus to evaluate frame geometry. WE MUST ACT NOW!
OCEAN-TAVI registry on mild PVL and TAVR long-term outcomes
jacc.org/doi/full/10.1016/j.…
Editorial
jacc.org/doi/full/10.1016/j.…
Routine Double-Tap in SAPIEN 3 Ultra Resilia
jacc.org/doi/10.1016/j.jcin.…
Real-time Fluoroscopic analysis of underexpansion in balloon-expandable TAVR
jacc.org/doi/full/10.1016/j.…
Editorial
jacc.org/doi/full/10.1016/j.…
⭐New insights from TRIPLACE featured at #PCRLV: PVL after #TTVR by @AndreaScotti21 et al.
🎯 6.1% w/ >/= mod PVL (predicted by large RA, malpositioning, type IV morphology)
🎯>/= mod translated into ⬆️1y mort
➡️May have key implications for procedural optimization+device design
RV remodelling data post Lux #TTVR from #PCRLV ⬆️
@PamelaGatto @alcantaramonica @dr_chrisallen @O_Azizy_MD @BenekiEirini @MiChen__ @juliendreyfus1 @jcecharte @DrGarot @cvnurselin @drtsakamoto @a_sorropago @TagliariPaula @m_taramasso @dr_tyxiong
































